Vaxcyte Inc
PCVXHealthcare·Biotechnology·USA·Large·NASD·Nov 11 • 3:59 PM ET
68.62+2.26 (3.41%)
2026-11-11 23:21 CET
Market cap
10,444.40 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-1,148.49 USD m
Free cash flow, TTM
-994.76 USD m
EPS diluted, TTM
-8.14
P/E
-
Price
PCVX against its 20, 50 and 200-day averages2050200beat
24.4% under the 52-week high of 90.75 on 5 Oct 2026. 52-week low 42.40 on 18 Dec 2025. Last 15 sessions, 16.4% high to low
Volume 0.76× normal · the line is the 50-bar volume average
Profile
PCVX52-week range, 54% of the way up
42.4090.75
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
| Index | RUT |
|---|---|
| Employees | 507 |
| IPO | Jun 12, 2020 |
| Beta | 1.28 |
| ATR, 14d | 3.46 |
| Rel volume | 0.76 |
| Short float | 9.99% |
| Insider own | 2.29% |
| Inst own | 110.03% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | 10.86B |
| Enterprise Value | 9.79B |
| Income | -1.15B |
| Sales | 0.00M |
| Book/sh | 16.67 |
| Cash/sh | 8.16 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 507 |
| IPO | Jun 12, 2020 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | - |
| P/B | 4.12 |
| P/C | 8.41 |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | - |
| Quick Ratio | 4.56 |
| Current Ratio | 4.56 |
| Debt/Eq | 0.09 |
| LT Debt/Eq | 0.08 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | -8.14 |
|---|---|
| EPS next Y | -6.68 |
| EPS next Q | -1.92 |
| EPS this Y | -39.63% |
| EPS next Y | 15.08% |
| EPS next 5Y | -4.87% |
| EPS past 3/5Y | -17.82% -26.39% |
| Sales past 3/5Y | - - |
| EPS Y/Y TTM | -65.42% |
| Sales Y/Y TTM | - |
| EPS Q/Q | -27.66% |
| Sales Q/Q | - |
| Earnings | Nov 04 AMC |
| EPS/Sales Surpr. | 5.88% - |
Ownership
| Insider Own | 2.29% |
|---|---|
| Insider Trans | -4.54% |
| Inst Own | 110.03% |
| Inst Trans | 3.15% |
| ROA | -37.28% |
| ROE | -42.68% |
| ROIC | -42.64% |
| Gross Margin | - |
| Oper. Margin | - |
| Profit Margin | - |
| SMA20 | 8.28% |
| SMA50 | 10.45% |
| SMA200 | 19.17% |
| Trades | - |
Technical
| Shs Outstand | 157.39M |
|---|---|
| Shs Float | 153.78M |
| Short Float | 9.99% |
| Short Ratio | 7.19 |
| Short Interest | 15.36M |
| 52W High | 90.75 -24.39% |
| 52W Low | 42.40 61.84% |
| Volatility | 6.42% 5.06% |
| ATR (14) | 3.46 |
| RSI (14) | 59.53 |
| Beta | 1.28 |
| Rel Volume | 0.76 |
| Avg Volume | 2.14M |
| Volume | 1,622,018 |
Performance
| Perf Week | 4.48% |
|---|---|
| Perf Month | 2.72% |
| Perf Quarter | 16.58% |
| Perf Half Y | 26.49% |
| Perf YTD | 48.72% |
| Perf Year | 50.28% |
| Perf 3Y | 42.54% |
| Perf 5Y | 166.38% |
| Perf 10Y | - |
| Recom | 1.20 |
| Target Price | 116.40 |
| Prev Close | 66.36 |
| Price | 68.62 |
| Change % | 3.41% |
Analyst ratings
latest 10 of 14| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Jan 07, 2026 | Reiterated | NNeedham | Buy | $90 → $110 | +60.3% |
| Sep 12, 2025 | Initiated | GGoldman | Neutral | $38 | -44.6% |
| Apr 22, 2025 | Initiated | CCantor Fitzgerald | Overweight | ||
| Dec 20, 2024 | Initiated | GGoldman | Buy | $135 | +96.7% |
| Dec 07, 2023 | Initiated | MMizuho | Buy | $69 | +0.6% |
| Apr 18, 2023 | Initiated | TTD Cowen | Outperform | ||
| Jan 03, 2023 | Reiterated | NNeedham | Buy | $52 → $58 | -15.5% |
| Dec 15, 2022 | Initiated | GGuggenheim | Buy | $66 | -3.8% |
| Nov 17, 2022 | Initiated | BBTIG Research | Buy | $69 | +0.6% |
| Dec 29, 2021 | Resumed | JJefferies | Buy | $50 | -27.1% |
Peers
Mkt capInsider trading
latest 14 of 72| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Cowan Elvia | SVP, Finance & CAO | Nov 02 '26 | Option Exercise | 25.92 | 3,000 | 77,760 | 30,860 | Nov 04 04:52 PM |
| Cowan Elvia | SVP, Finance & CAO | Nov 02 '26 | Sale | 60.92 | 3,000 | 182,753 | 27,860 | Nov 04 04:52 PM |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Nov 02 '26 | Option Exercise | 5.35 | 2,250 | 12,038 | 147,685 | Nov 04 04:51 PM |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Nov 02 '26 | Sale | 60.90 | 2,250 | 137,024 | 145,435 | Nov 04 04:51 PM |
| Wassil Jim | Officer | Nov 02 '26 | Proposed Sale | 61.88 | 2,250 | 139,230 | Nov 02 04:16 PM | |
| Cowan Elvia | Officer | Nov 02 '26 | Proposed Sale | 61.88 | 3,000 | 185,640 | Nov 02 04:07 PM | |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 05 '26 | Option Exercise | 5.35 | 18,000 | 96,300 | 163,435 | Oct 07 04:08 PM |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 05 '26 | Sale | 86.74 | 18,000 | 1,561,320 | 145,435 | Oct 07 04:08 PM |
| Cowan Elvia | SVP, Finance & CAO | Oct 05 '26 | Option Exercise | 25.92 | 19,000 | 492,480 | 46,860 | Oct 07 04:07 PM |
| Cowan Elvia | SVP, Finance & CAO | Oct 05 '26 | Sale | 86.74 | 19,000 | 1,648,060 | 27,860 | Oct 07 04:07 PM |
| Cowan Elvia | Officer | Oct 05 '26 | Proposed Sale | 86.74 | 19,000 | 1,648,060 | Oct 05 04:10 PM | |
| Wassil Jim | Officer | Oct 05 '26 | Proposed Sale | 86.74 | 18,000 | 1,561,320 | Oct 05 04:09 PM | |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 01 '26 | Option Exercise | 5.35 | 2,250 | 12,038 | 147,685 | Oct 02 04:05 PM |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 01 '26 | Sale | 56.67 | 2,250 | 127,513 | 145,435 | Oct 02 04:05 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.38B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| XBI | State Street SPDR S&P Biotech ETF | AUM: 10.50B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.34B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
| TCAF | T. Rowe Price Capital Appreciation Equity ETF | AUM: 7.62B |
| IBB | iShares Biotechnology ETF | AUM: 11.36B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.06B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.25B |
News
latest 14 of 200- Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire) +8.01% -5.72%
- BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits) +9.79%
- Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares and Convertible Senior Notes (GlobeNewswire)
- Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes (GlobeNewswire) -9.65%
- Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers (Investor's Business Daily)
- As Expected: Vaxcyte Announces $1 Billion Stock and Convertible Raise a Day After Its Phase 3 Win (and Sinks 10%) (TIKR)
- Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results (Quartz)
- MARKETS LIVE: US futures climb after Nasdaq record close (Proactive)
- Pfizers $6.49 Billion Prevnar Franchise Faces a New Challenger (TIKR)
- NVAX Stock Outruns Moderna As Vaxcytes Shot Clears A Late-Stage Test (Stocktwits) +30.70%
- Vaxcyte stock falls on $1B dual offering launch (Investing.com)
- Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes (GlobeNewswire)
- PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit Blue-Sky Case (Stocktwits)
- Drug stocks show rare weakness amid fears of vaccine competition (MarketWatch)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-04 | -1.990 | -2.114 | -1.990 | 0.00 | 0.00 | 9 |
| 2026Q2 | 2026-08-05 | -1.970 | -2.056 | -1.968 | 0.00 | 0.00 | 9 |
| 2026Q1 | 2026-05-06 | -2.300 | -1.778 | -2.298 | 0.00 | 0.00 | 8 |
| 2025Q4 | 2026-02-24 | -1.810 | -1.530 | -1.881 | 0.00 | 0.00 | 9 |
| 2025Q3 | 2025-11-04 | -1.560 | -1.238 | -1.563 | 0.00 | 0.00 | 10 |
| 2025Q2 | 2025-08-06 | -1.220 | -1.160 | -1.225 | 0.00 | 0.00 | 8 |
| 2025Q1 | 2025-05-07 | -1.040 | -1.061 | -1.037 | 0.00 | 0.00 | 7 |
| 2024Q4 | 2025-02-25 | -1.020 | -1.107 | -1.098 | 0.00 | 0.00 | 9 |
| 2024Q3 | 2024-11-05 | -0.830 | -1.101 | -0.834 | 0.00 | 0.00 | 9 |
| 2024Q2 | 2024-08-06 | -1.100 | -0.976 | -1.098 | 0.00 | 0.00 | 9 |
| 2024Q1 | 2024-05-08 | -0.850 | -1.129 | -0.851 | 0.00 | 0.00 | 9 |
| 2023Q4 | 2024-02-27 | -1.830 | -1.054 | -1.896 | 0.00 | 0.00 | 9 |
| 2023Q3 | 2023-11-06 | -0.910 | -0.838 | -0.911 | 0.00 | 0.00 | 8 |
| 2023Q2 | 2023-08-08 | -0.700 | -0.745 | -0.697 | 0.00 | 0.00 | 8 |
| 2023Q1 | 2023-05-08 | -0.700 | -0.822 | -0.701 | 0.00 | 0.00 | 8 |
| 2022Q4 | 2023-02-27 | -1.030 | -0.930 | -1.028 | 0.00 | 0.00 | 7 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2020FY | -3.020 | -5.433 | -1.747 | 0.00 | 0.50 |
| 2021FY | -1.930 | -1.933 | -1.927 | 0.00 | 0.00 |
| 2022FY | -3.440 | -3.334 | -3.445 | 0.00 | 0.00 |
| 2023FY | -4.140 | -3.423 | -4.140 | 0.00 | 0.00 |
| 2024FY | -3.800 | -3.911 | -3.803 | 0.00 | 0.00 |
| 2025FY | -5.630 | -5.437 | -5.630 | 0.00 | 0.00 |
| 2026FY | - | -7.861 | - | - | 0.00 |
| 2027FY | - | -6.676 | - | - | 68.89 |
| 2028FY | - | -6.493 | - | - | 74.89 |
| 2029FY | - | -3.128 | - | - | 941.44 |
| 2030FY | - | 2.190 | - | - | 1,953 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-05 | 7 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-11-04 | 7 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-10-07 | 7 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-10-05 | 6 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-08-06 | 7 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-06-05 | 6 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-05-11 | 7 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-05-07 | 7 | 0 | 1 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2026-02-25 | 5 | 0 | 1 | 0.00 | 0.00 | 0.00 |
| 2026Q4 | S | 2025-11-11 | 3 | 0 | 0 | 12.50 | 0.00 | 37.50 |
| 2026Q4 | S | 2025-11-10 | 3 | 0 | 0 | 12.50 | 0.00 | 37.50 |
| 2026Q4 | S | 2025-11-09 | 3 | 0 | 0 | 12.50 | 0.00 | 37.50 |
| 2026Q4 | S | 2025-11-08 | 3 | 0 | 0 | 12.50 | 0.00 | 37.50 |
| 2026Q4 | S | 2025-11-07 | 3 | 0 | 0 | 12.50 | 0.00 | 37.50 |
Estimate history
| EPS, annual | -0.604 | -1.029 | -1.747 | -1.927 | -3.445 | -4.14 | -3.803 | -5.633 | -8.1416 |
|---|---|---|---|---|---|---|---|---|---|
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | -0.834 | -1.098 | -1.037 | -1.225 | -1.563 | -1.881 | -2.298 | -1.968 | -1.995 |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
| Sales, annual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
| Shares, annual | 48.858 | 48.858 | 51.072 | 53.032 | 79.471 | 95.365 | 124.893 | 131.059 | 149.299 |
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 124.43 | 124.893 | 128.939 | 129.816 | 130.029 | 131.059 | 144.315 | 144.786 | 149.299 |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 29.68 | 24.86 | 15.85 | 10.17 | 9.20 | 1.80 | 1.41 | 1.23 | 1.04 |
| Gross Profit | -29.68 | -24.86 | -15.85 | -10.17 | -9.20 | -1.80 | -1.41 | -1.23 | -1.04 |
| Selling, General and Administrative Excl. Other | 1,201.50 | 898.82 | 553.70 | 382.87 | 200.06 | 101.87 | 88.18 | 52.92 | 34.50 |
| Research and Development | 1,093.02 | 794.31 | 476.64 | 332.34 | 169.45 | 78.41 | 73.56 | 45.61 | 30.14 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1,231.18 | -923.67 | -569.55 | -393.04 | -209.26 | -103.67 | -89.58 | -54.15 | -35.53 |
| Interest Expense | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.07 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 75.00 | 23.00 | 0.00 | - | -3.19 | -5.18 |
| Net Income Before Taxes | -1,148.49 | -766.63 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | -29.48 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -1,148.49 | -766.63 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | -29.48 |
| Net Income From Continuing Operations | -1,148.49 | -766.63 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | -29.48 |
| Net Income | -1,148.49 | -766.63 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | -29.48 |
| EPS (Recurring) | -7.71 | -5.63 | -3.80 | -3.60 | -3.20 | -1.93 | -1.75 | -1.07 | -0.68 |
| EPS (Basic, Before Extraordinaries) | -8.14 | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -1.75 | -1.03 | -0.60 |
| EPS (Diluted) | -8.14 | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -1.75 | -1.03 | -0.60 |
| EBITDA | -1,201.50 | -898.82 | -553.70 | -382.87 | -200.06 | -101.87 | -88.18 | -52.92 | -34.50 |
| Non-Operating Income (Expense) | 82.69 | 157.05 | 105.62 | 65.78 | 8.77 | 3.59 | 0.37 | 0.73 | 0.94 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 156.30 | 138.84 | 84.82 | 48.76 | 23.65 | 10.73 | 5.43 | 1.19 | 0.75 |
| Shares Outstanding | 149.30 | 131.06 | 124.89 | 95.36 | 79.47 | 53.03 | 51.07 | 48.86 | 48.86 |
| Market Capitalization | 10,444.40 | 10,444.40 | 10,202.78 | 5,975.66 | 3,787.10 | 1,255.76 | 1,353.73 | 1,475.50 | - |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 8.10 | 5.93 | 5.85 | 9.80 | 5.20 | 4.99 | 4.87 | 4.79 |
| Gross Profit | -8.10 | -5.93 | -5.85 | -9.80 | -5.20 | -4.99 | -4.87 | -4.79 |
| Selling, General and Administrative Excl. Other | 300.17 | 296.85 | 340.00 | 264.48 | 237.18 | 221.23 | 175.92 | 157.38 |
| Research and Development | 270.33 | 267.85 | 312.78 | 242.06 | 209.93 | 194.18 | 148.13 | 133.61 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -308.27 | -302.78 | -345.85 | -274.28 | -242.38 | -226.22 | -180.79 | -162.17 |
| Interest Expense | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -297.06 | -284.30 | -320.62 | -246.51 | -212.83 | -166.57 | -140.72 | -137.08 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -297.06 | -284.30 | -320.62 | -246.51 | -212.83 | -166.57 | -140.72 | -137.08 |
| Net Income From Continuing Operations | -297.06 | -284.30 | -320.62 | -246.51 | -212.83 | -166.57 | -140.72 | -137.08 |
| Net Income | -297.06 | -284.30 | -320.62 | -246.51 | -212.83 | -166.57 | -140.72 | -137.08 |
| EPS (Recurring) | -1.99 | -1.97 | -2.30 | -1.88 | -1.56 | -1.22 | -1.04 | -1.10 |
| EPS (Basic, Before Extraordinaries) | -1.99 | -1.97 | -2.30 | -1.88 | -1.56 | -1.22 | -1.04 | -1.10 |
| EPS (Diluted) | -1.99 | -1.97 | -2.30 | -1.88 | -1.56 | -1.22 | -1.04 | -1.10 |
| EBITDA | -300.17 | -296.85 | -340.00 | -264.48 | -237.18 | -221.23 | -175.92 | -157.38 |
| Non-Operating Income (Expense) | 11.21 | 18.48 | 25.23 | 27.78 | 29.55 | 59.65 | 40.08 | 31.27 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 41.10 | 41.24 | 37.96 | 36.00 | 35.31 | 36.93 | 30.61 | 24.37 |
| Shares Outstanding | 149.30 | 144.79 | 144.31 | 131.06 | 130.03 | 129.82 | 128.94 | 124.89 |
| Market Capitalization | 10,444.40 | 8,393.86 | 8,363.19 | 6,040.00 | 4,676.22 | 4,193.92 | 4,862.05 | 10,202.78 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 1,560.96 | 1,747.21 | 1,080.23 | 931.38 | 245.97 | 386.20 | 58.98 | 66.09 |
| Short Term Receivables | 46.56 | 20.66 | 3.61 | 1.00 | 1.20 | 0.30 | 0.20 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 19.84 | 20.11 | 12.12 | 10.18 | 9.18 | 2.50 | 2.55 | 0.58 |
| Total Current Assets | 1,627.36 | 1,787.98 | 1,095.95 | 942.55 | 256.35 | 389.00 | 61.72 | 66.67 |
| Net Property, Plant & Equipment | 491.72 | 332.62 | 110.62 | 31.65 | 35.91 | 3.27 | 3.39 | 3.41 |
| Total Investments and Advances | 883.13 | 1,388.83 | 163.78 | 27.42 | 27.99 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 43.25 | 21.98 | - | - | - | - | - | - |
| Other Assets | 0.51 | 1.88 | 37.56 | 4.55 | 4.09 | 0.55 | 0.58 | 0.72 |
| Total Assets | 3,045.97 | 3,533.30 | 1,407.92 | 1,006.18 | 324.34 | 392.83 | 65.70 | 70.80 |
| Short Term Debt Incl. Current Port. of LT Debt | 6.12 | 5.89 | 7.11 | 5.91 | 5.28 | 0.00 | 0.16 | 0.30 |
| Accounts Payable | 70.90 | 48.45 | 14.59 | 9.79 | 6.76 | 29.79 | 3.38 | 2.83 |
| Other Current Liabilities | 128.72 | 85.84 | 123.64 | 24.82 | 16.68 | 17.08 | 7.51 | 3.59 |
| Total Current Liabilities | 205.75 | 140.18 | 145.34 | 40.52 | 28.72 | 46.86 | 11.05 | 6.71 |
| Long Term Debt | 111.36 | 65.22 | 22.11 | 12.03 | 11.51 | 0.00 | 0.00 | 0.16 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 43.25 | 21.98 | - | - | - | - | - | - |
| Other Liabilities | 0.10 | 0.10 | 0.00 | 0.01 | 0.10 | 0.12 | 0.71 | 3.85 |
| Total Liabilities | 360.45 | 227.48 | 167.45 | 52.56 | 40.32 | 46.98 | 11.76 | 10.72 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 160.31 | 117.81 |
| Common Equity | 2,685.51 | 3,305.82 | 1,240.47 | 953.61 | 284.02 | 345.84 | -106.37 | -57.73 |
| Total Shareholders Equity | 2,685.51 | 3,305.82 | 1,240.47 | 953.61 | 284.02 | 345.84 | 53.94 | 60.08 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 2,685.51 | 3,305.82 | 1,240.47 | 953.61 | 284.02 | 345.84 | 53.94 | 60.08 |
| Total Liabilities & Stockholders Equity | 3,045.97 | 3,533.30 | 1,407.92 | 1,006.18 | 324.34 | 392.83 | 65.70 | 70.80 |
| Book Value Per Share | 20.49 | 26.47 | 13.01 | 12.00 | 5.36 | 6.77 | -2.18 | -1.18 |
| Tangible Book Value Per Share | 20.49 | 26.47 | 13.01 | 12.00 | 5.36 | 6.77 | -2.18 | -1.18 |
| Full-Time Employees | 507 | 414 | 254 | 158 | 89 | 58 | - | - |
| Price to Book Ratio | 3.98 | 2.98 | 4.26 | 8.08 | 4.44 | 3.92 | 4.05 | - |
| Return on Assets | -23.30 | -18.78 | -33.33 | -33.59 | -27.91 | -38.91 | -73.66 | - |
| Return on Equity | -25.59 | -20.41 | -36.67 | -36.11 | -31.78 | -44.63 | -88.19 | - |
| Return on Invested Capital | -27.41 | -13.76 | -31.86 | -23.14 | -33.86 | -25.80 | -93.21 | -48.94 |
| Quick Ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 | 8.30 | 5.58 | 9.93 |
| Current Ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 | 8.30 | 5.58 | 9.93 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1,148.49 | -766.63 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | -29.48 |
| Depreciation | 29.68 | 24.86 | 15.85 | 10.17 | 9.20 | 3.46 | 1.41 | 1.23 | 1.04 |
| Other Funds (Non Cash) | 169.43 | 89.64 | 50.35 | 13.98 | 30.95 | 12.23 | 5.91 | -3.11 | -3.91 |
| Funds from Operations | -949.39 | -652.12 | -397.73 | -378.11 | -183.33 | -84.39 | -81.90 | -52.15 | -32.36 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -12.62 | -3.45 | -54.90 | 81.32 | 12.74 | -37.01 | 35.27 | 3.91 | 1.90 |
| Cash from Operating Activities | -962.01 | -655.58 | -452.63 | -296.79 | -170.60 | -121.39 | -46.63 | -48.24 | -30.47 |
| Capital Expenditures | -32.75 | -56.97 | -119.16 | -67.88 | -5.85 | -6.55 | -1.16 | -1.20 | -1.77 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.05 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 232.96 | 494.33 | -1,886.51 | -705.43 | 80.43 | -205.78 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -1,381.77 | -1,211.50 | -3,086.70 | -1,329.90 | -102.75 | -336.34 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 1,614.73 | 1,705.83 | 1,200.19 | 624.46 | 183.17 | 130.56 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 200.21 | 437.35 | -2,005.67 | -773.31 | 74.58 | -212.31 | -1.10 | -1.20 | -1.77 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 629.37 | 13.01 | 2,462.80 | 643.69 | 862.41 | 17.80 | 374.93 | 42.94 | 62.47 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 629.37 | 13.01 | 2,462.80 | 643.69 | 862.41 | 17.80 | 374.93 | 42.94 | 62.47 |
| Proceedsfrom Stock Options | -9.59 | 0.00 | 2,435.66 | 638.08 | 857.51 | 14.78 | 374.26 | 42.50 | 62.34 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.28 | -0.28 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.28 | -0.28 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.28 | -0.28 |
| Net Financing Active Other Cash Flow | -25.00 | -10.99 | -14.29 | -3.88 | -0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -25.00 | -10.99 | -14.29 | -3.88 | -0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 604.37 | 2.01 | 2,448.51 | 639.81 | 861.55 | 17.80 | 374.87 | 42.66 | 62.19 |
| Exchange Rate Effect | 1.61 | 2.44 | 0.43 | -6.69 | 0.14 | -0.44 | 0.09 | -0.34 | 0.00 |
| Net Change in Cash | -155.83 | -213.77 | -9.36 | -436.97 | 765.67 | -316.34 | 327.22 | -7.11 | 29.95 |
| Free Cash Flow | -994.76 | -712.55 | -571.79 | -364.67 | -176.44 | -127.95 | -47.78 | -49.44 | -32.24 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 1,292.23 | 1,486.84 | 1,737.18 | 1,560.96 | 1,711.32 | 1,661.43 |
| Short Term Receivables | 0.00 | 0.00 | 0.00 | 46.56 | 0.40 | 0.10 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 57.33 | 65.83 | 76.31 | 19.84 | 55.45 | 54.25 |
| Total Current Assets | 1,349.56 | 1,552.67 | 1,813.49 | 1,627.36 | 1,767.17 | 1,715.78 |
| Net Property, Plant & Equipment | 662.93 | 370.57 | 373.80 | 491.72 | 337.00 | 327.92 |
| Total Investments and Advances | 973.41 | 1,022.36 | 1,005.48 | 883.13 | 960.72 | 1,166.41 |
| Deferred Tax Assets | - | - | - | 43.25 | - | - |
| Other Assets | 3.25 | 192.56 | 155.54 | 0.51 | 106.71 | 95.26 |
| Total Assets | 2,989.14 | 3,138.15 | 3,348.31 | 3,045.97 | 3,171.60 | 3,305.36 |
| Short Term Debt Incl. Current Port. of LT Debt | 17.61 | 6.51 | 6.08 | 6.12 | 5.77 | 6.30 |
| Accounts Payable | 67.61 | 100.92 | 63.06 | 70.90 | 48.96 | 31.41 |
| Other Current Liabilities | 210.47 | 163.85 | 172.94 | 128.72 | 145.31 | 116.77 |
| Total Current Liabilities | 295.70 | 271.28 | 242.08 | 205.75 | 200.05 | 154.49 |
| Long Term Debt | 204.22 | 108.94 | 110.21 | 111.36 | 78.67 | 79.54 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | 43.25 | - | - |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
| Total Liabilities | 499.92 | 380.21 | 352.29 | 360.45 | 278.72 | 234.03 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 2,489.22 | 2,757.94 | 2,996.01 | 2,685.51 | 2,892.88 | 3,071.33 |
| Total Shareholders Equity | 2,489.22 | 2,757.94 | 2,996.01 | 2,685.51 | 2,892.88 | 3,071.33 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 2,489.22 | 2,757.94 | 2,996.01 | 2,685.51 | 2,892.88 | 3,071.33 |
| Total Liabilities & Stockholders Equity | 2,989.14 | 3,138.15 | 3,348.31 | 3,045.97 | 3,171.60 | 3,305.36 |
| Book Value Per Share | 16.67 | 19.05 | 20.76 | 20.49 | 22.25 | 23.66 |
| Tangible Book Value Per Share | 16.67 | 19.05 | 20.76 | 20.49 | 22.25 | 23.66 |
| Full-Time Employees | - | - | - | 507 | - | - |
| Price to Book Ratio | 3.98 | 2.80 | 2.84 | 2.07 | 1.52 | 1.31 |
| Return on Assets | -37.28 | -33.03 | -28.14 | -23.30 | -19.53 | -20.31 |
| Return on Equity | -42.68 | -36.51 | -30.55 | -25.59 | -20.83 | -21.65 |
| Return on Invested Capital | -11.03 | -9.92 | -10.32 | -8.81 | -7.16 | -5.29 |
| Quick Ratio | 4.56 | 5.72 | 7.49 | 7.91 | 8.83 | 11.11 |
| Current Ratio | 4.56 | 5.72 | 7.49 | 7.91 | 8.83 | 11.11 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | -297.06 | -284.30 | -320.62 | -246.51 | -212.83 | -166.57 |
| Depreciation | 8.10 | 5.93 | 5.85 | 9.80 | 5.20 | 4.99 |
| Other Funds (Non Cash) | 55.56 | 45.23 | 37.05 | 31.58 | 32.25 | 6.73 |
| Funds from Operations | -233.40 | -233.14 | -277.71 | -205.13 | -175.38 | -154.86 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 9.32 | 0.67 | -2.91 | -19.70 | 32.08 | 33.69 |
| Cash from Operating Activities | -224.08 | -232.47 | -280.62 | -224.83 | -143.31 | -121.17 |
| Capital Expenditures | -4.96 | -4.57 | -14.79 | -8.42 | -12.05 | -9.76 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 175.73 | 152.29 | -218.62 | 123.55 | 133.22 | 87.50 |
| Purchase of Investments | -236.32 | -268.68 | -584.13 | -292.65 | -255.31 | -349.05 |
| Sale Or Maturity of Investments | 412.05 | 420.97 | 365.51 | 416.19 | 388.53 | 436.55 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 170.77 | 147.72 | -233.41 | 115.12 | 121.17 | 77.74 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 7.32 | 7.76 | 610.88 | 3.42 | 0.31 | 3.23 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 7.32 | 7.76 | 610.88 | 3.42 | 0.31 | 3.23 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | -9.59 | 0.31 | 9.28 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -12.64 | -2.06 | -9.29 | -1.01 | -3.98 | -0.72 |
| Other Financing Activities Uses | -12.64 | -2.06 | -9.29 | -1.01 | -3.98 | -0.72 |
| Cash from Financing Activities | -5.33 | 5.70 | 601.58 | 2.41 | -3.67 | 2.52 |
| Exchange Rate Effect | 0.70 | 1.40 | -0.66 | 0.18 | 0.29 | 0.80 |
| Net Change in Cash | -57.93 | -77.65 | 86.88 | -107.12 | -25.52 | -40.11 |
| Free Cash Flow | -229.04 | -237.04 | -295.42 | -233.25 | -155.35 | -130.92 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 9.99% | 15.4M | 153.8M | 2.06M |
| 2026-10-15 | 9.51% | 14.6M | 153.8M | 1.83M |
| 2026-09-30 | 11.89% | 17.3M | 145.4M | 1.14M |
| 2026-09-15 | 11.10% | 16.1M | 145.4M | 1.30M |
| 2026-08-31 | 10.33% | 15.0M | 145.4M | 1.32M |
| 2026-08-14 | 10.18% | 14.8M | 145.4M | 1.43M |
| 2026-07-31 | 9.95% | 14.5M | 145.4M | 1.57M |
| 2026-07-15 | 10.10% | 14.2M | 140.9M | 1.60M |
| 2026-06-30 | 12.39% | 17.5M | 140.9M | 1.62M |
| 2026-06-15 | 10.38% | 14.6M | 140.9M | 1.43M |
| 2026-05-29 | 10.25% | 14.5M | 141.2M | 1.41M |
| 2026-05-15 | 9.77% | 13.8M | 141.2M | 1.36M |
| 2026-04-30 | 10.05% | 14.1M | 140.8M | 1.35M |
| 2026-04-15 | 10.23% | 14.4M | 140.3M | 1.44M |
| 2026-03-31 | 9.76% | 13.7M | 140.2M | 1.40M |
| 2026-03-13 | 9.32% | 13.1M | 140.2M | 1.37M |
| 2026-02-27 | 9.45% | 13.3M | 140.2M | 1.42M |
| 2026-02-13 | 9.81% | 13.8M | 140.2M | 1.45M |
| 2026-01-30 | 8.68% | 12.0M | 137.8M | 1.39M |
| 2026-01-15 | 9.52% | 12.1M | 127.1M | 1.34M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 30.00 | 36.30 | 41.00 | 0.00 | 4.919 | 0.00 | 0.00 | 0.970 | -0.139 | 0.007 |
| call | 35.00 | 31.30 | 36.00 | 0.00 | 4.153 | 0.00 | 0.00 | 0.964 | -0.136 | 0.009 |
| call | 40.00 | 26.10 | 31.00 | 0.00 | 3.494 | 0.00 | 0.00 | 0.956 | -0.132 | 0.010 |
| call | 45.00 | 21.10 | 25.90 | 18.00 | 2.864 | 2.00 | 0.00 | 0.947 | -0.126 | 0.012 |
| call | 50.00 | 16.20 | 21.00 | 14.60 | 2.381 | 7.00 | 0.00 | 0.934 | -0.119 | 0.014 |
| call | 55.00 | 11.50 | 16.00 | 8.30 | 1.889 | 380 | 0.00 | 0.915 | -0.110 | 0.017 |
| call | 60.00 | 6.50 | 10.30 | 4.80 | 1.195 | 464 | 0.00 | 0.833 | -0.153 | 0.027 |
| call | 65.00 | 4.10 | 6.20 | 4.10 | 0.990 | 452 | 1.00 | 0.658 | -0.249 | 0.039 |
| call | 70.00 | 1.45 | 3.00 | 1.75 | 0.842 | 479 | 5.00 | 0.469 | -0.208 | 0.042 |
| call | 75.00 | 0.00 | 1.00 | 0.45 | 0.723 | 725 | 0.00 | 0.241 | -0.141 | 0.033 |
| call | 80.00 | 0.00 | 1.20 | 0.15 | 1.002 | 36.00 | 3.00 | 0.184 | -0.162 | 0.028 |
| call | 85.00 | 0.00 | 1.20 | 0.05 | 1.241 | 310 | 0.00 | 0.157 | -0.181 | 0.026 |
| call | 90.00 | 0.00 | 1.50 | 0.20 | 1.453 | 550 | 0.00 | 0.139 | -0.196 | 0.024 |
| call | 95.00 | 0.00 | 2.25 | 0.00 | 1.644 | 0.00 | 0.00 | 0.127 | -0.208 | 0.022 |
| call | 100 | 0.00 | 1.15 | 0.00 | 1.819 | 0.00 | 0.00 | 0.118 | -0.218 | 0.021 |
| call | 105 | 0.00 | 1.15 | 0.00 | 1.980 | 0.00 | 0.00 | 0.111 | -0.227 | 0.020 |
| call | 110 | 0.00 | 4.40 | 0.00 | 2.131 | 0.00 | 0.00 | 0.105 | -0.235 | 0.019 |
| call | 115 | 0.00 | 1.15 | 0.00 | 2.272 | 0.00 | 0.00 | 0.100 | -0.242 | 0.019 |
| call | 120 | 0.00 | 4.90 | 0.00 | 2.404 | 0.00 | 0.00 | 0.096 | -0.248 | 0.018 |
| call | 125 | 0.00 | 4.90 | 0.00 | 2.528 | 0.00 | 0.00 | 0.092 | -0.254 | 0.018 |
| call | 130 | 0.00 | 4.90 | 0.00 | 2.646 | 0.00 | 0.00 | 0.089 | -0.259 | 0.017 |
| call | 135 | 0.00 | 3.40 | 0.00 | 2.758 | 10.00 | 0.00 | 0.087 | -0.264 | 0.017 |
| put | 30.00 | 0.00 | 4.90 | 0.08 | 3.284 | 10.00 | 0.00 | -0.030 | -0.136 | 0.007 |
| put | 35.00 | 0.00 | 3.00 | 0.18 | 2.742 | 11.00 | 0.00 | -0.036 | -0.132 | 0.009 |
| put | 40.00 | 0.00 | 2.70 | 0.35 | 2.271 | 7.00 | 0.00 | -0.044 | -0.127 | 0.010 |
| put | 45.00 | 0.00 | 4.90 | 0.20 | 1.851 | 12.00 | 0.00 | -0.053 | -0.121 | 0.012 |
| put | 50.00 | 0.00 | 0.80 | 0.20 | 1.469 | 233 | 0.00 | -0.066 | -0.114 | 0.014 |
| put | 55.00 | 0.00 | 0.50 | 0.05 | 1.113 | 67.00 | 2.00 | -0.085 | -0.104 | 0.017 |
| put | 60.00 | 0.00 | 1.00 | 0.25 | 0.979 | 1,905 | 5.00 | -0.167 | -0.147 | 0.027 |
| put | 65.00 | 0.30 | 3.10 | 1.65 | 1.139 | 226 | 0.00 | -0.342 | -0.242 | 0.039 |
| put | 70.00 | 1.65 | 4.40 | 3.50 | 0.863 | 64.00 | 1.00 | -0.531 | -0.200 | 0.042 |
| put | 75.00 | 5.00 | 9.00 | 8.70 | 1.182 | 10.00 | 0.00 | -0.759 | -0.133 | 0.033 |
| put | 80.00 | 9.40 | 14.00 | 8.85 | 1.372 | 1.00 | 0.00 | -0.816 | -0.153 | 0.028 |
| put | 85.00 | 14.10 | 18.90 | 14.30 | 1.762 | 1.00 | 0.00 | -0.843 | -0.172 | 0.026 |
| put | 90.00 | 19.30 | 24.00 | 16.70 | 2.039 | 0.00 | 0.00 | -0.861 | -0.186 | 0.024 |
| put | 95.00 | 24.00 | 28.70 | 0.00 | 2.167 | 0.00 | 0.00 | -0.873 | -0.197 | 0.022 |
| put | 100 | 29.00 | 33.70 | 0.00 | 2.367 | 0.00 | 0.00 | -0.882 | -0.207 | 0.021 |
| put | 105 | 34.00 | 38.70 | 0.00 | 2.551 | 0.00 | 0.00 | -0.889 | -0.215 | 0.020 |
| put | 110 | 39.00 | 43.70 | 0.00 | 2.722 | 0.00 | 0.00 | -0.895 | -0.222 | 0.019 |
| put | 115 | 44.00 | 48.70 | 0.00 | 2.881 | 0.00 | 0.00 | -0.900 | -0.229 | 0.019 |
| put | 120 | 49.00 | 53.70 | 0.00 | 2.956 | 0.00 | 0.00 | -0.904 | -0.235 | 0.018 |
| put | 125 | 54.00 | 58.70 | 0.00 | 3.095 | 0.00 | 0.00 | -0.908 | -0.240 | 0.018 |
| put | 130 | 59.00 | 63.70 | 0.00 | 3.305 | 0.00 | 0.00 | -0.911 | -0.245 | 0.017 |
| put | 135 | 64.00 | 68.70 | 0.00 | 3.431 | 0.00 | 0.00 | -0.913 | -0.249 | 0.017 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-06 | SCHEDULE 13G/A | SEC | ||
| 2026-11-06 | SCHEDULE 13G/A | SEC | ||
| 2026-11-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-02 | SEC |
| 2026-11-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-02 | SEC |
| 2026-11-04 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-11-02 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-02 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-09 | 8-K | Current report | 2026-10-06 | SEC |
| 2026-10-08 | 424B5 | SEC | ||
| 2026-10-08 | 424B5 | SEC | ||
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-05 | SEC |
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-05 | SEC |
| 2026-10-07 | FWP | Filing under Securities Act Rule 163/433 of free writing prospectuses. | SEC | |
| 2026-10-06 | 305B2 | Application for designation of a new trustee under the Trust Indenture Act | SEC | |
| 2026-10-06 | 424B5 | SEC | ||
| 2026-10-06 | 424B5 | SEC | ||
| 2026-10-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-05 | 8-K | Current report | 2026-10-05 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-01 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-04 | SEC |
| 2026-09-09 | 3 | Initial statement of beneficial ownership of securities | 2026-08-31 | SEC |
| 2026-09-09 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-04 | SEC |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 319.78K | 2 |
| 2026-10 | 0 | 0 | 3.34M | 3 |
| 2026-09 | 0 | 0 | 376.21K | 3 |
| 2026-08 | 0 | 0 | 1.60M | 3 |
| 2026-07 | 0 | 0 | 1.71M | 4 |
| 2026-06 | 0 | 0 | 3.26M | 6 |
| 2026-05 | 0 | 0 | 127.87K | 1 |
| 2026-04 | 0 | 0 | 311.48K | 2 |
| 2026-03 | 0 | 0 | 687.07K | 3 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 1.01M | 2 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| FMR LLC | 15.11% |
| Jupiter Topco LLC | 12.44% |
| T. Rowe Price Investment Management, Inc. | 8.45% |
| BlackRock, Inc. | 8.36% |
| RA CAPITAL MANAGEMENT, L.P. | 7.95% |
| WELLINGTON MANAGEMENT GROUP LLP | 4.85% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.57% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.40% |
| STATE STREET CORP | 3.71% |
| Deep Track Capital, LP | 2.98% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.18% |
| T. Rowe Price Capital Appreciation Fund | 2.78% |
| iShares Russell 2000 ETF | 2.35% |
| VANGUARD SMALL-CAP INDEX FUND | 2.29% |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 2.11% |
| Janus Henderson Forty Fund | 1.85% |
| VANGUARD HEALTH CARE FUND | 1.62% |
| Janus Henderson Enterprise Fund | 1.57% |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1.52% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.32% |
OakChart. PCVX. Cached 15 minutes.